XGEVA 120 mg/1 ml, Injektionslösung in einer Fertigspritze
7680695200010
CH-69520
Injektionslösung
Associated product:
XGEVA sol inj 120 mg/ml ser pré 1 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
denosumabum
|
120.0 MG | Substance | Wirkstoff (Principe actif) |
|
sorbitolum
|
37.0 MG | Substance | HBESI |
|
phenylalaninum
|
6.1 MG | Substance | HBESI |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
polysorbatum 20
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 269.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Amgen Switzerland AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69520
- Drug name
- XGEVA, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- M05BX04
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 18/09/2024
- Authorization expiration date
- 17/09/2029
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- XGEVA sol inj 120 mg/ml ser pré 1 ml
- Description (DE)
- XGEVA Inj Lös 120 mg/ml Fertspr 1 ml
- Market launch
- 18/09/2024
- Narcotic (BTM)
- No